To further assess the effects of SD70 on leukemia cell growth and disease development in vivo, we labeled the primary AML cells carrying MLL fusion (MLL3) with a luciferase reporter prior to their transplantation into NSG mice for either the vehicle or SD70 in vivo treatment. The gene discussed is KMT2A; the disease is leukemia.